XtalPi and Astellas Venture Management contributed to a $45.6m round that took the drug discovery technology provider's total funding to over $60m.

Parkwalk Advisors has returned to back a $46m round for PhoreMost, weeks after the latter’s spinout Neophore attracted $21m in a series B.

Returning corporate backer Go-Ventures took part in a pre-series B round for investment app developer Pluang as it looks to launch a government bond-focused product.

Cash Capital has participated in a $70m series B round for Shanghai ZhenGe Biotechnology, bringing the company’s total financing to $125m.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The Strides-backed protein and peptide-based therapeutics developer has disclosed a $70m series B and $125m C round, valuing it at $350m post-money.

Wipro Ventures helped Vulcan Cyber take its overall funding to $35m as it prepares to launch a free version of its cybersecurity remediation management product.

Eli Lilly and Novartis Venture Fund participated in a round that will support the progress of Amphista's protein degradation drug candidates toward clinical trials.

Forbion and Gilde Healthcare have co-led a $53m series B round for Dundee spinout Amphista, which is working on targeted protein degradation technology.

Existing corporate investor Vorwerk Ventures contributed to an $11.9m round that will support the expansion of Rebike's e-bike rental service.